MANNKIND CORP(NASDAQ:MNKD) stock News

MNKD Latest News, Press Relases and Analysis

All

Press Releases

13 days ago - By: Zacks Investment Research - Mentions: DNLI

Why Is Denali Therapeutics (DNLI) Up 16.2% Since Last Earnings Report?

14 days ago - By: Benzinga - Mentions: INSM CNC MOH UNH ...

10 Health Care Stocks Whale Activity In Today's Session

20 days ago - By: Stocktwits - Mentions: UTHR

MannKind Lands A Price-Target Hike After Partner United Therapeutics Reports Strong Lung Drug Trial Results

21 days ago - By: Benzinga - Mentions: SBSW ULCC CIFR APO ...

Air Lease, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday

a month ago - By: Stocktwits - Mentions: UTHR

MannKind, United Therapeutics Expand Agreement To Develop A Second Investigational Molecule Together

a month ago - By: Zacks Investment Research - Mentions: CVGI INBK

New Strong Sell Stocks for August 27th

2 months ago - By: Stocktwits - Mentions: BX

MannKind Announces $500M Financing Agreement With Blackstone After Q2 Revenue Miss: Retail Believes Stock Is ‘Ridiculously Undervalued’

25 days ago - By: Yahoo Finance

MannKind Corporation (MNKD) Seeks FDA Pediatric Approval for Afrezza

26 days ago - By: Brodsky & Smith LLC - Mentions: SCPH VTLE IMXI HBI ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: scPharmaceuticals Inc. (Nasdaq – SCPH), Vital Energy, Inc. (NYSE – VTLE), International Money Express, Inc. (Nasdaq - IMXI), HanesBrands Financial Corp. (NYSE - HBI)

a month ago - By: MannKind

MannKind to Present at Upcoming Investor Conferences

a month ago - By: MannKind

MannKind to Present at Upcoming Investor Conferences

a month ago - By: MannKind

MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy

a month ago - By: MannKind

MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy

a month ago - By: Stocktwits - Mentions: SCPH

MannKind’s $360M scPharma Deal Splits Analysts — Retail Traders Call It ‘Bizarro Territory’ But Stay Bullish

a month ago - By: Stocktwits - Mentions: SCPH

MannKind Corporation to Acquire scPharmaceuticals: More Details Inside

a month ago - By: MannKind

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases

a month ago - By: MannKind - Mentions: SCPH

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases

a month ago - By: Yahoo Finance

Leerink Partners Reiterates a Buy on MannKind Corporation (MNKD), Keeps the PT

a month ago - By: Yahoo Finance

MannKind (MNKD) Secures $500M Financing to Advance Inhaled Therapies Pipeline

2 months ago - By: The Motley Fool

MannKind (MNKD) Q2 Revenue Rises 6%

2 months ago - By: Zacks Investment Research

MannKind (MNKD) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

2 months ago - By: Zacks Investment Research - Mentions: PHAT

MannKind (MNKD) Reports Break-Even Earnings for Q2

2 months ago - By: MannKind

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

2 months ago - By: MannKind

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

2 months ago - By: MannKind

MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update

2 months ago - By: MannKind

MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update

2 months ago - By: MannKind

MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025

2 months ago - By: MannKind

MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025

2 months ago - By: Yahoo Finance - Mentions: WFC

Wells Fargo Maintains a Buy Rating on MannKind Corporation (MNKD), Sets a $9 PT

3 months ago - By: Yahoo Finance

Leerink Partners Slashes MannKind Corporation’s (MNKD) Price Target to $7, Keeps a Buy Rating

3 months ago - By: Yahoo Finance

MANNKIND CORP (MNKD) Stock News

MNKD Latest News, Press Relases and Analysis

Why Is Denali Therapeutics (DNLI) Up 16.2% Since Last Earnings Report?

10 Health Care Stocks Whale Activity In Today's Session

MannKind Lands A Price-Target Hike After Partner United Therapeutics Reports Strong Lung Drug Trial Results

Air Lease, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday

MannKind, United Therapeutics Expand Agreement To Develop A Second Investigational Molecule Together

New Strong Sell Stocks for August 27th

MannKind Announces $500M Financing Agreement With Blackstone After Q2 Revenue Miss: Retail Believes Stock Is ‘Ridiculously Undervalued’

MannKind Corporation (MNKD) Seeks FDA Pediatric Approval for Afrezza

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: scPharmaceuticals Inc. (Nasdaq – SCPH), Vital Energy, Inc. (NYSE – VTLE), International Money Express, Inc. (Nasdaq - IMXI), HanesBrands Financial Corp. (NYSE - HBI)

MannKind to Present at Upcoming Investor Conferences

MannKind to Present at Upcoming Investor Conferences

MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy

MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy

MannKind’s $360M scPharma Deal Splits Analysts — Retail Traders Call It ‘Bizarro Territory’ But Stay Bullish

MannKind Corporation to Acquire scPharmaceuticals: More Details Inside

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases

Leerink Partners Reiterates a Buy on MannKind Corporation (MNKD), Keeps the PT

MannKind (MNKD) Secures $500M Financing to Advance Inhaled Therapies Pipeline

MannKind (MNKD) Q2 Revenue Rises 6%

MannKind (MNKD) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

MannKind (MNKD) Reports Break-Even Earnings for Q2

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update

MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update

MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025

MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025

Wells Fargo Maintains a Buy Rating on MannKind Corporation (MNKD), Sets a $9 PT

Leerink Partners Slashes MannKind Corporation’s (MNKD) Price Target to $7, Keeps a Buy Rating

MannKind (MNKD) Presents Pediatric Insulin Trial Data